Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: The ICARIA study-Reference-Cited by-同舟云学术

Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: The ICARIA study

Published:2021-12 Issue: Volume:338 Page:39-45
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Sánchez-Ramos Andrea,Fernández-Labandera Carlos,Vallejo-Vaz Antonio J.,Bonacho Eva Calvo^ORCID,Quevedo-Aguado Luis,Catalina-Romero Carlos,Valdivielso Pedro^ORCID,Sánchez-Chaparro Miguel Ángel

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis;Hu;Circulation,2020

2. Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects;Beheshti;J. Am. Coll. Cardiol.,2020

3. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

4. Homozygous familial hypercholesterolemia in Spain;Sánchez-Hernández;Circ. Cardiovasc. Genet.,2016

5. [Homozygous familial hypercholesterolaemia: Spanish adaptation of the position paper from the consensus panel on familial hypercholesterolaemia of the European atherosclerosis society. Consensus document of the Spanish society of arteriosclerosis (SEA) an;Ascaso;Clín. Invest. Arterioscler.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis;European Heart Journal;2024-07-08

2. Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia;Atherosclerosis Plus;2022-12

3. El laboratorio clínico en la prevención cardiovascular: el caso de los mapas coropléticos;REC: CardioClinics;2022-10